![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 10
Zeitschriftenartikel
Jacob, Anne Sophie; Kaul, Helen; Fuchs, Michael; Gillessen, Sarah; Kreissl, Stefanie; Pluetschow, Annette; Momotow, Jesko; Schaub, Valdete; Huettmann, Andreas; Haenel, Mathias; Zimmermann, Andreas; Dierlamm, Judith; Meissner, Julia; Mathas, Stephan; Martin, Sonja; Engert, Andreas; Hallek, Michael; Borchmann, Peter und Lehmann, Clara
(2022):
Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma.
In: Infection, Bd. 50, Nr. 4: S. 925-932
Middeke, Jan M.; Metzeler, Klaus H.; Roellig, Christoph; Kraemer, Michael; Eckardt, Jan-Niklas; Stasik, Sebastian; Greif, Philipp A.; Spiekermann, Karsten; Rothenberg-Thurley, Maja; Krug, Utz; Braess, Jan; Kraemer, Alwin; Hochhaus, Andreas; Bruemmendorf, Tim H.; Naumann, Ralph; Steffen, Bjoern; Einsele, Hermann; Schaich, Markus; Burchert, Andreas; Neubauer, Andreas; Goerlich, Dennis; Sauerland, Cristina; Schaefer-Eckart, Kerstin; Schliemann, Christoph; Krause, Stefan W.; Haenel, Mathias; Frickhofen, Norbert; Noppeney, Richard; Kaiser, Ulrich; Kaufmann, Martin; Kunadt, Desiree; Woermann, Bernhard; Sockel, Katja; Bonin, Malte von; Herold, Tobias; Mueller-Tidow, Carsten; Platzbecker, Uwe; Berdel, Wolfgang E.; Serve, Hubert; Baldus, Claudia D.; Ehninger, Gerhard; Schetelig, Johannes; Hiddemann, Wolfgang; Bornhaeuser, Martin; Stoelzel, Friedrich und Thiede, Christian
(2022):
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study.
In: Blood Advances, Bd. 6, Nr. 5: S. 1394-1405
Kunadt, Desiree; Stasik, Sebastian; Metzeler, Klaus H.; Roellig, Christoph; Schliemann, Christoph; Greif, Philipp A.; Spiekermann, Karsten; Rothenberg-Thurley, Maja; Krug, Utz; Braess, Jan; Kraemer, Alwin; Hochhaus, Andreas; Scholl, Sebastian; Hilgendorf, Inken; Bruemmendorf, Tim H.; Jost, Edgar; Steffen, Bjoern; Bug, Gesine; Einsele, Hermann; Goerlich, Dennis; Sauerland, Cristina; Schaefer-Eckart, Kerstin; Krause, Stefan W.; Haenel, Mathias; Hanoun, Maher; Kaufmann, Martin; Woermann, Bernhard; Kramer, Michael; Sockel, Katja; Egger-Heidrich, Katharina; Herold, Tobias; Ehninger, Gerhard; Burchert, Andreas; Platzbecker, Uwe; Berdel, Wolfgang E.; Mueller-Tidow, Carsten; Hiddemann, Wolfgang; Serve, Hubert; Stelljes, Matthias; Baldus, Claudia D.; Neubauer, Andreas; Schetelig, Johannes; Thiede, Christian; Bornhaeuser, Martin; Middeke, Jan M. und Stoelzel, Friedrich
(2022):
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation.
In: Journal of Hematology & Oncology, Bd. 15, Nr. 1, 126
Frontzek, Fabian; Ziepert, Marita; Nickelsen, Maike; Altmann, Bettina; Glass, Bertram; Haenel, Mathias; Truemper, Lorenz; Held, Gerhard; Bentz, Martin; Borchmann, Peter; Dreyling, Martin; Viardot, Andreas; Kroschinsky, Frank P.; Metzner, Bernd; Staiger, Annette M.; Horn, Heike; Ott, German; Rosenwald, Andreas; Loeffler, Markus; Lenz, Georg und Schmitz, Norbert
(2021):
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial.
In: Lancet Haematology, Bd. 8, Nr. 4, E267-E277
Hirt, Carsten; Hoster, Eva; Unterhalt, Michael; Haenel, Mathias; Prange-Krex, Gabriele; Forstpointner, Roswitha; Florschuetz, Axel; Graeven, Ullrich; Frickhofen, Norbert; Wulf, Gerald; Lengfelder, Eva; Lerchenmueller, Christian; Schlag, Rudolf; Dierlamm, Judith; Fischer von Weikersthal, Ludwig; Ahmed, Asima; Harich, Hanns-Detlev; Rosenwald, Andreas; Klapper, Wolfram; Dreyling, Martin; Hiddemann, Wolfgang und Herold, Michael
(2021):
Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hamatologie und Onkologie and the German Low-Grade Lymphoma Study Group.
In: Hemasphere, Bd. 5, Nr. 7, e600
Rautenberg, Christina; Stoelzel, Friedrich; Roellig, Christoph; Stelljes, Matthias; Gaidzik, Verena; Lauseker, Michael; Kriege, Oliver; Verbeek, Mareike; Unglaub, Julia Marie; Thol, Felicitas; Krause, Stefan W.; Haenel, Mathias; Neuerburg, Charlotte; Vucinic, Vladan; Jehn, Christian-Friedrich; Severmann, Julia; Wass, Maxi; Fransecky, Lars; Chemnitz, Jens; Holtick, Udo; Schaefer-Eckart, Kerstin; Schroeder, Josephine; Kraus, Sabrina; Krueger, William; Kaiser, Ulrich; Scholl, Sebastian; Koch, Kathrin; Henning, Lea; Kobbe, Guido; Haas, Rainer; Alakel, Nael; Roehnert, Maximilian-Alexander; Sockel, Katja; Hanoun, Maher; Platzbecker, Uwe; Holderried, Tobias A. W.; Morgner, Anke; Heuser, Michael; Sauer, Tim; Goetze, Katharina S.; Wagner-Drouet, Eva; Doehner, Konstanze; Doehner, Hartmut; Schliemann, Christoph; Schetelig, Johannes; Bornhaeuser, Martin; Germing, Ulrich; Schroeder, Thomas und Middeke, Jan Moritz
(2021):
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.
In: Blood Cancer Journal, Bd. 11, Nr. 10, 164
Schmitz, Norbert; Truemper, Lorenz; Bouabdallah, Krimo; Ziepert, Marita; Leclerc, Mathieu; Cartron, Guillaume; Jaccard, Arnaud; Reimer, Peter; Wagner, Eva; Wilhelm, Martin; Sanhes, Laurence; Lamy, Thierry; de Leval, Laurence; Rosenwald, Andreas; Roussel, Muriel; Kroschinsky, Frank; Lindemann, Walter; Dreger, Peter; Viardot, Andreas; Milpied, Noeel; Gisselbrecht, Christian; Wulf, Gerald; Gyan, Emmanuel; Gaulard, Philippe; Bay, Jacques Olivier; Glass, Bertram; Poeschel, Viola; Damaj, Gandhi; Sibon, David; Delmer, Alain; Bilger, Karin; Banos, Anne; Haenel, Mathias; Dreyling, Martin; Metzner, Bernd; Keller, Ulrich; Braulke, Friederike; Friedrichs, Birte; Nickelsen, Maike; Altmann, Bettina und Tournilhac, Olivier
(2021):
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
In: Blood, Bd. 137, Nr. 19: S. 2646-2656
Kebir, Sied; Schaub, Christina; Junold, Nina; Hattingen, Elke; Schäfer, Niklas; Steinbach, Joachim P.; Weyerbrock, Astrid; Hau, Peter; Goldbrunner, Roland; Galldiks, Norbert; Weller, Johannes; Mack, Frederic; Tzaridis, Theophilos; Baehr, Oliver; Seidel, Clemens; Schlegel, Uwe; Schmidt-Graf, Friederike; Rohde, Veit; Borchers, Christian; Tabatabai, Ghazaleh; Haenel, Mathias; Sabel, Michael; Gerlach, Rüdiger; Krex, Dietmar; Belka, Claus; Vatter, Hartmut; Proescholdt, Martin; Glas, Martin und Herrlinger, Ulrich
(2019):
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
In: Journal of Neuro-Oncology, Bd. 144, Nr. 3: S. 501-509
Friedrichs, Birte; Nickelsen, Maike; Ziepert, Marito; Altmann, Bettina; Haenel, Mathias; Viardot, Andreas; Schmidt, Christian; Ruebe, Christian; Löffler, Markus; Pfreundschuh, Michael; Rosenwald, Andreas; Glass, Bertram; Lenz, Georg und Schmitz, Norbert
(2019):
Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial.
In: British Journal of Haematology, Bd. 184, Nr. 5: S. 760-768
Schaub, Christina; Kebir, Sied; Junold, Nina; Hattingen, Elke; Schäfer, Niklas; Steinbach, Joachim P.; Weyerbrock, Astrid; Hau, Peter; Goldbrunner, Roland; Niessen, Michael; Mack, Frederic; Stuplich, Moritz; Tzaridis, Theophilos; Bähr, Oliver; Kortmann, Rolf-Dieter; Schlegel, Uwe; Schmidt-Graf, Friederike; Rohde, Veit; Braun, Christian; Haenel, Mathias; Sabel, Michael; Gerlach, Rüdiger; Krex, Dietmar; Belka, Claus; Vatter, Hartmut; Pröscholdt, Martin; Herrlinger, Ulrich und Glas, Martin
(2018):
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
In: Journal of Cancer Research and Clinical Oncology, Bd. 144, Nr. 8: S. 1581-1589